A shorter, higher-dose radiation treatment for prostate cancer is just as safe and effective as conventional radiotherapy, according to a UCLA co-led study published Wednesday. The study evaluated isodose moderately hypofractionated radiotherapy (MHFRT), which delivers slightly higher doses of radiation per session, shortening treatment from seven to eight weeks down to four to five weeks. […]
